V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007750 | 290004886 | 1.65 | 0 | Disease modification (D) | 2017-10-21 | 2017-10-21 | PACLITAXEL | 2 | null | 290019285 | Y-90 |
| 290007751 | 290004889 | 1.77 | null | Curative (C) | 2014-08-20 | 2014-08-26 | PEMBROLIZUMAB | null | N | 290019304 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007752 | 290008271 | 1.63 | null | Palliative (P) | 2018-02-03 | 2018-04-10 | Cetuximab + Radiotherapy Load | N | Y | 290019305 | CETUXIMAB |
| 290007753 | 290004893 | 1.77 | 56.3 | Palliative (P) | 2015-11-16 | 2015-12-16 | REGORAFENIB | N | N | 290019365 | DOXORUBICIN + OLARATUMAB |
| 290007754 | 290004894 | 1.65 | 74.9 | Adjuvant (A) | 2016-11-06 | 2016-11-08 | Capecitabine + Oxaliplatin 14day | 02 | Y | 290019376 | CAPECITABINE + RT |
| 290007755 | 290004895 | 1.81 | null | Curative (C) | null | 2014-03-17 | CETUXIMAB + RT | N | Y | 290019383 | ETOPOSIDE + IFOSFAMIDE |
| 290007756 | 290004898 | 1.77 | 63 | Disease modification (D) | null | 2018-03-26 | Y-90 | null | Y | 290019407 | CARBOPLATIN + ETOPOSIDE |
| 290007757 | 290004902 | null | 63.9 | Curative (C) | 2015-12-20 | 2016-01-31 | Capecitabine + Oxaliplatin 21day | N | N | 290019408 | CARBOPLATIN + RT |
| 290007758 | 290004903 | 1.5 | 48 | Palliative (P) | 2016-07-11 | 2016-07-14 | CARBOPLATIN + PACLITAXEL | N | null | 290019412 | CISPLATIN + RALTITREXED + TRASTUZUMAB |
| 290007759 | 290004907 | 1.66 | 71.35 | Palliative (P) | 2017-09-10 | 2018-03-03 | Cisplatin 7 day | N | N | 290019428 | INTERAACT TRIAL |
| 290007760 | 290004907 | 1.81 | 65 | Palliative (P) | 2016-08-07 | 2016-08-10 | Capecitabine | N | Y | 290019428 | CAPECITABINE + OXALIPLATIN |
| 290007761 | 290004912 | 1.8 | 55.5 | null | 2018-02-24 | 2018-02-24 | MCX | 02 | N | 290019465 | CETUXIMAB |
| 290007762 | 290004916 | 1.75 | 81.2 | Curative (C) | 2016-11-08 | 2016-11-28 | Capecitabine | N | N | 290019481 | CETUXIMAB |
| 290007763 | 290004918 | 1.68 | null | Not known (9) | null | 2018-08-05 | LENALIDOMIDE | N | null | 290019498 | DHAP - R |
| 290007764 | 290004920 | 1.74 | 51.5 | Palliative (P) | 2017-10-11 | 2017-10-19 | Cisplatin + Radiotherapy | N | N | 290019528 | CAPECITABINE |
| 290007765 | 290004922 | 1.62 | 68.4 | null | 2017-12-03 | 2017-12-03 | Capecitabine | N | N | 290019537 | LANREOTIDE |
| 290007766 | 290004924 | 1.64 | 67.2 | Curative (C) | 2017-07-12 | 2018-04-04 | CAPECITABINE + OXALIPLATIN | N | N | 290019570 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007767 | 290004927 | 1.75 | 87.95 | Curative (C) | null | 2018-02-23 | LENALIDOMIDE | N | N | 290019591 | CAPECITABINE + OXALIPLATIN |
| 290007768 | 290004929 | 1.76 | 55.5 | Curative (C) | null | 2018-02-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290019597 | ESHAP |
| 290007769 | 290004930 | 1.64 | 118 | Curative (C) | null | 2016-04-28 | EVEROLIMUS | N | N | 290019600 | CETUXIMAB |
| 290007770 | 290004933 | 1.6 | 50 | null | 2018-11-30 | 2018-12-27 | Carboplatin + Etoposide IV 3 day | N | N | 290019621 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007771 | 290004934 | 1.87 | 67.2 | Curative (C) | 2010-06-15 | 2015-03-25 | IBRUTINIB | N | N | 290019622 | CAPECITABINE + OXALIPLATIN |
| 290007772 | 290004936 | 1.77 | 101.3 | Palliative (P) | 2017-04-19 | 2018-02-23 | LANREOTIDE | N | N | 290019646 | IBRUTINIB |
| 290007773 | 290004937 | 1.83 | null | null | 2015-04-20 | 2015-04-26 | CAPECITABINE + OXALIPLATIN | 02 | N | 290019647 | NOT MATCHED |
| 290007774 | 290004939 | 1.73 | null | Adjuvant (A) | 2016-09-01 | 2017-01-13 | FLUOROURACIL + MITOMYCIN | N | null | 290019648 | CISPLATIN + RT |
| 290007775 | 290004940 | 1.6 | 88.4 | null | 2017-12-18 | 2017-12-24 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290019660 | CISPLATIN |
| 290007776 | 290004942 | 1.81 | null | Palliative (P) | 2015-01-25 | 2015-02-22 | Cisplatin + Etoposide po&iv 3 day | N | null | 290019674 | TRASTUZUMAB + VINORELBINE |
| 290007777 | 290004945 | null | 78.6 | Palliative (P) | 2016-10-16 | 2016-11-05 | Docetaxel | 2 | N | 290019693 | CAPECITABINE |
| 290007778 | 290004950 | 1.75 | 61.2 | Adjuvant (A) | 2018-03-03 | 2018-12-05 | Cisplatin + Radiotherapy | N | N | 290019730 | CAPECITABINE + OXALIPLATIN |
| 290007779 | 290004954 | 1.58 | 58.9 | Palliative (P) | 2017-04-18 | 2017-05-02 | Carboplatin + Etoposide IV 3 day | N | N | 290019773 | CETUXIMAB |
| 290007780 | 290004957 | 1.64 | 83 | Palliative (P) | 2018-04-01 | 2019-03-18 | Trastuzumab Subcutaneous | 02 | N | 290019781 | SUNITINIB |
| 290007781 | 290004960 | 1.86 | null | Disease modification (D) | 2014-08-29 | 2015-02-07 | CETUXIMAB | N | N | 290019795 | CARBOPLATIN + ETOPOSIDE |
| 290007782 | 290004963 | 1.53 | 61 | Adjuvant (A) | 2014-11-13 | 2015-01-08 | CARBOPLATIN + FLUOROURACIL | N | Y | 290019798 | CAPECITABINE + OXALIPLATIN |
| 290007783 | 290007957 | 1.69 | 33.5 | Adjuvant (A) | 2018-02-06 | 2018-02-13 | Capecitabine + Oxaliplatin 21day | 02 | N | 290019805 | CAPECITABINE |
| 290007784 | 290004966 | 1.6 | null | Palliative (P) | 2017-04-13 | 2017-04-13 | LANREOTIDE | 02 | N | 290019811 | CARBOPLATIN + PACLITAXEL |
| 290007785 | 290004979 | 1.53 | 44.1 | Palliative (P) | null | 2017-08-10 | MITOMYCIN | N | N | 290019915 | NIVOLUMAB |
| 290007786 | 290004980 | 1.67 | 78.1 | Palliative (P) | null | 2016-11-04 | CARBOPLATIN + RT | N | N | 290019949 | Y-90 |
| 290007787 | 290004980 | 0 | 63.4 | Palliative (P) | 2017-12-09 | 2018-01-31 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 290019949 | DOCETAXEL |
| 290007788 | 290007103 | 1.74 | 62.7 | Adjuvant (A) | 2018-04-13 | 2018-04-20 | TRASTUZUMAB | null | N | 290019957 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 290007789 | 290004984 | 1.8 | 37 | Curative (C) | null | 2017-09-16 | Sunitinib | N | N | 290019960 | CAPECITABINE + OXALIPLATIN |
| 290007790 | 290004989 | null | 60.1 | Disease modification (D) | 2013-10-17 | 2013-10-25 | OCTREOTIDE | N | N | 290019998 | CHOP R |
| 290007791 | 290007106 | null | 61 | null | 2018-10-02 | 2019-03-23 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290020014 | FLUOROURACIL + MITOMYCIN |
| 290007792 | 290007107 | 1.62 | 56.4 | Palliative (P) | 2016-08-18 | 2016-08-19 | Capecitabine | 2 | N | 290020038 | CAPECITABINE + STREPTOZOCIN |
| 290007793 | 290004997 | 1.66 | 67.8 | null | 2017-07-20 | 2017-07-21 | Capecitabine + Oxaliplatin 21day | 2 | N | 290020049 | CAPECITABINE + OXALIPLATIN |
| 290007794 | 290005003 | null | null | Adjuvant (A) | 2016-06-13 | 2016-06-24 | Capecitabine | 02 | null | 290020090 | GEMCITABINE |
| 290007795 | 290005004 | null | 106.8 | null | 2018-09-13 | 2018-09-14 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290020091 | CISPLATIN + RT |
| 290007796 | 290005009 | 1.63 | 52 | Palliative (P) | 2017-08-22 | 2017-10-11 | Cisplatin + Radiotherapy | n | N | 290020156 | PANITUMUMAB |
| 290007797 | 290005009 | 1.61 | 87 | Palliative (P) | 2015-08-19 | 2015-08-30 | Liposomal Doxorubicin 40mg/m2 | Y | N | 290020156 | DOCETAXEL |
| 290007798 | 290007113 | 1.8 | 71.1 | Adjuvant (A) | 2017-05-27 | 2017-05-30 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | Y | 290020172 | CAPECITABINE + OXALIPLATIN |
| 290007799 | 290005015 | 1.68 | 53.2 | Disease modification (D) | 2018-07-20 | 2018-09-01 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 290020188 | Y-90 |